Position in JNJ
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$621,479,319
-$15,409,100 QoQ
Shares Held
2,447,058
-6.1% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#85
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aberdeen Group plc holds $3,276,463,441 across 12 Drug Manufacturers - General names. JNJ ranks #2 (19.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
682,818 | $818,992,461 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
2,447,058 | $621,479,319 | |
| 3 | MRK |
Merck & Co., Inc.
|
4,309,756 | $553,803,646 | |
| 4 | ABBV |
AbbVie Inc.
|
2,052,285 | $516,436,996 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
3,222,190 | $185,662,586 | |
| 6 | AMGN |
Amgen Inc
|
489,514 | $177,262,808 | |
| 7 | PFE |
Pfizer Inc
|
6,163,309 | $148,412,479 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,003,515 | $126,784,084 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $621,479,319 | 2,447,058 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $636,888,419 | 2,605,500 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $525,339,884 | 2,538,487 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $461,786,839 | 2,490,491 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $416,862,233 | 2,729,049 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $449,194,058 | 2,708,599 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $281,735,811 | 1,948,111 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $334,353,600 | 2,063,147 | Shares | Defined | 2024-10-25 | |
| 2024-06-30 | $317,623,949 | 2,173,125 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $302,914,866 | 1,914,880 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $315,790,817 | 2,014,743 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $153,772,285 | 987,302 | Shares | Defined | 2023-11-07 | |
| 2023-06-30 | $185,942,518 | 1,123,384 | Shares | Defined | 2024-06-20 | |
| 2023-03-31 | $168,853,900 | 1,089,380 | Shares | Defined | 2024-06-20 | |
| 2022-12-31 | $196,963,334 | 1,114,992 | Shares | Defined | 2024-06-20 | |
| 2022-09-30 | $171,302,888 | 1,048,622 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $197,947,077 | 1,115,132 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $191,703,486 | 1,081,665 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $241,657,071 | 1,412,621 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $259,110,436 | 1,604,399 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $282,256,780 | 1,713,347 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $441,975,275 | 2,689,232 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $409,682,641 | 2,603,143 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $394,037,269 | 2,646,677 | Shares | Defined | 2020-10-21 | |
| 2020-06-30 | $394,998,869 | 2,808,781 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $384,636,675 | 2,933,247 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||